← Leaderboards
Hanh Ngoc Lam
University Of California Santa Cruz
$787,714
Attributed
$787,714
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2019–23$250K$187.5K$125K$62.5K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$787,714 · 2
By mechanism
R00$489,709 · 1
K99$298,005 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Santa Cruz
Same institution · by research overlap
- Charles L Ortiz$6,390,140
- Victoria Auerbuch Stone$7,086,241
- Laura Margaret Sanchez$2,229,601
- R Scott Lokey$7,777,813
- Theodore R Holman$8,552,369
Others in their field
Other Emerging Leaders on “Consumption”
- John E Schulenberg · University Of Michigan At Ann Arbor$8,135,202
- Jessica Scott · Sloan-Kettering Inst Can Research$8,125,046
- Frederick Porter · Duke University$7,614,516
- Alexander Egbe · Mayo Clinic Rochester$7,415,297
- Ashlee Fitch · Steelworker Charitable/Educational Org$7,332,339
- Kelly G Pennell · University Of Kentucky$7,138,732
Research focus
ConsumptionFutureClinically RelevantComputer AssistedDrug DiscoveryFoundationsAntibioticsAcute InfectionCombinatorialAntimicrobial DrugCostAspartateAffinityEnzyme ActivationBindingBinding ProteinsBiochemicalAntibiotic TherapyCofactorCalorimetryCause Of DeathCell DeathAntibiotic ResistanceGlobal Health
Grant awards (5)
Combinatorial approach to develop novel pre-therapeutic agents targeting virulence factors essential to clinically relevant pathogens$240,709
R00 · FY2023 · AI · contact PI
Combinatorial approach to develop novel pre-therapeutic agents targeting virulence factors essential to clinically relevant pathogens$249,000
R00 · FY2022 · AI · contact PI
Combinatorial approach to develop novel pre-therapeutic agents targeting virulence factors essential to clinically relevant pathogens$61,557
K99 · FY2021 · AI · contact PI
Combinatorial approach to develop novel pre-therapeutic agents targeting virulence factors essential to clinically relevant pathogens$118,224
K99 · FY2020 · AI · contact PI
Combinatorial approach to develop novel pre-therapeutic agents targeting virulence factors essential to clinically relevant pathogens$118,224
K99 · FY2019 · AI · contact PI